# FDA recall D-1165-2018

> **Auro Pharmacies, Inc.** · Class II · drug recall initiated 2018-08-21.

## Product

Testosterone Enanthate/Cypionate injectable, 126/54 mg/mL, packaged in a) 3 mL and b) 5 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

## Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

## Distribution

Nationwide in USA

## Key facts

- **Recall number:** D-1165-2018
- **Recalling firm:** Auro Pharmacies, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-08-21
- **Report date:** 2018-09-05
- **Termination date:** 2020-01-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** La Habra, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1165-2018

## Citation

> AI Analytics. FDA recall D-1165-2018. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-1165-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*